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A b s t r a c t
Background: Psychological profile (PsyP) of patients with transient loss of consciousness (TLoC) is evidence of high prevalence 
of anxiety and depression. However, the mechanistic link between abnormal PsyP and TLoC is still unclear. 
Aim: This study aimed to evaluate: 1) prevalence of abnormal PsyP in TLoC patients; 2) cardiac autonomic response to head-up 
tilt test (HUTT) in patients with (PsyP+) or without abnormal PsyP (PsyP–), developing syncope (HUTT+) or not (HUTT–). 
Methods: Forty-one patients (66% female, mean age 36 ± 15 years), with history of TLoC, underwent PsyP before HUTT. 
Short-term heart rate variability analysis was carried out under baseline rest condition and at peak heart rate and/or onset of 
syncope induced by nitroglycerine (NTG), during HUTT. 
Results: HUTT+ occurred in 17/41 patients, more frequently in females, who had higher levels of anxiety (p < 0.0001). 
PsyP+ was prevalent in 70.5% of HUTT+ patients (p < 0.05). Among PsyP+ patients HUTT+ had dominant sympathetic 
modulation (DSM) at rest, which increased at the onset of syncope, whereas in HUTT patients vagal modulation was prevalent 
at rest. Among NTG-induced HUTT+ patients, fourfold higher increases of very low frequency (VLF) power were found in 
PsyP– compared with PsyP+. 
Conclusions: 58% of patients with history of TLoC were PsyP+. In PsyP+ patients, DSM at rest correlates with higher prob-
ability of NTG-induced syncope, which occurs with 60% increment of low frequency and 530% increment of VLF power. 
Conversely, in patients with prevalent vagal modulation at rest and a decrease in VLF power after NTG, syncope did not occur. 
This supports interpretation of VLF power as an index of stress-induced sympathetic activity. 
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INTRODUCTION
Syncope is defined as a transient loss of consciousness (TLoC), 
usually characterised by spontaneous, rapid, and complete 
recovery [1, 2]. Clinical presentation of vasovagal syncope, 
the most common cause of neurally mediated TLoC, varies 
from typical (characterised by prodromal symptoms as nausea, 
vomiting, abdominal pain, pallor, sweating, and the presence 
of precipitating factors such as emotional distress or orthostatic 
stress) to atypical pattern (no evident trigger and no prodromal 
symptoms), or unexplained fall, or syncope during sleep [1]. 
Although the diagnosis of vasovagal syncope can be confirmed 
with head-up tilt test (HUTT), alone or potentiated with nitro-
glycerine (NTG) [3, 4], the pathophysiology of individual TLoC 
is not always clearly understood [5], especially in the absence of 
structural cardiac and neurological abnormalities. Moreover, the 
psychological profile (PsyP) of patients with TLoC is evidence of 
higher levels of anxiety, fear [5, 6], panic, and depression (that 
ranges between 15% and 30% of cases) [7, 8], with impaired 
quality of life [5], which can be improved by psychological 
intervention such as cognitive and behavioural therapy [9].
Since the mechanistic role of abnormal PsyP (PsyP+) 
in the genesis of TLoC is still uncertain, this study aimed to 
evaluate whether baseline cardiovascular autonomic nerv-
ous system (CANS) modulation and/or HUTT-induced CANS 
response, evaluated with heart rate variability analysis (HRVa) 
[10–12], could be different as a function of individual PsyP 
and useful to predict and/or understand the mechanism of 
syncope at HUTT. More specifically we aimed to:
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 — define the PsyP of patients undergoing HUTT for history 
of TLoC;
 — evaluate if higher level of anxiety and/or depression was 
correlated with specific HRVa patterns;
 — evaluate if the integration of PsyP, HRVa, and HUTT 
outcome could improve the understanding of patho-
physiological mechanisms underlying TLoC, based on 
the hypothesis that PsyP+ might have a pathogenetic 
role in the occurrence of TLoC, through a specific pat-
tern of CANS. 
Our hypotheses were that:
 — PsyP+ was prevalent in patients with history of TLoC; 
 — higher level of anxiety should be associated with domi-
nant sympathetic modulation (DSM) at baseline rest and 
with higher incidence of HUTT-induced syncope;
 — prevalent vagal modulation should be found in patients 
with normal PsyP (PsyP–), having a protective effect 
against the induction of syncope at HUTT.
METHODS
Patients 
Data of 41 consecutive patients (14 males and 27 females, 
mean age 36 ± 15 years), with clinical history of one or 
more TLoC episodes and referred for HUTT between January 
2014 and April 2016, were retrieved form our clinical data-
base. Syncope was defined according to European Society of 
Cardiology (ESC) guidelines [3]. 
All patients were free from other diseases that could 
have an impact on the outcome of the study. In particular, 
patients with structural cardiac or neurological disease (includ-
ing movement disorder diseases), hypoglycaemia, diabetes, 
drug intoxication, positional vertigo, or any other abnormality 
potentially affecting heart rate (HR) variability were excluded. 
None of the patients had been previously diagnosed with 
depression/anxiety.
All patients had been investigated for clinical needs, in 
agreement with good clinical practice rules and the declara-
tion of Helsinki, after written, informed consent. 
Psychological assessment 
As a routine screening, all patients had filled out the following 
four questionnaires before HUTT:
 — Zung Self-Rating Anxiety Scale [13]: a 20-item self-report 
assessment device, where overall assessment is done by 
total raw scores ranging from 20 to 80 (20–40: normal 
range; 45–59: mild to moderate anxiety level; 60–74: 
marked to severe anxiety level; 75–80: extreme anxi-
ety levels);
 — Spielberger’s State Trait Anxiety Inventory (STAI) [14]: 
a) Y1, 20 items for assessing “trait anxiety”, i.e. the anxi-
ety the patient feels coming in contact with a stressor;
b) Y2, 20 items for “state anxiety”, i.e. the tendency to 
react with anxiety during everyday life;
 — Zung Self-Rating Depression Scale [15]: short self-ad-
ministered survey based on 20 items on the scale, which 
rates the affective, psychological, and somatic symptoms 
associated with depression. The scores fall into four ranges 
(20–44: normal; 45–59: mildly depressed; 60–69: mod-
erately depressed; 70 and above: severely depressed);
 — Beck Depression Questionnaire [16], i.e. multiple-choose 
self-report inventories measuring depression severity:
a) BDI: 21 questions (10–19: minimal depression; 
20–29: moderate depression; > 30: severe depression);
b) BDI-II: 21 questions (0–13: minimal depression; 
14–19: mild depression; 20–28: moderate depres-
sion; 29–63: severe depression); 
c) BDI-PC: 7 questions (0–3: minimal depression; 4–6: 
mild depression; 7–9: moderate depression; 10–21: 
severe depression). 
Depression and/or anxiety were diagnosed whenever 
one test was scored severely positive or two tests were scored 
moderately positive.
HUTT 
HUTT was carried out following the Italian protocol [4], in 
the morning (range 8.30–12 a.m.), in a quiet room, with the 
patient fasting from 8 h, under continuous 12-lead telemetric 
electrocardiogram, non-invasive blood pressure (BP), and 
oxygen saturation monitoring. After a supine rest of 20 min, 
the patient was tilted to 60 degrees for 20 min; if syncope or 
pre-syncope were not induced, sublingual NTG spray (dos-
age 300 µg) was administrated. A positive HUTT response 
(HUTT+) was defined if syncope (or pre-syncope character-
ised by systolic BP decrease and/or bradycardia/asystole) oc-
curred. Syncope was classified as type I, mixed (HR decreases 
during syncope but does not drop below 40 bpm, or drops be-
low 40 bpm for < 10 s, with or without asystole < 3 s, and BP 
decreases before HR fall); type II, cardio-inhibitory (type IIA: 
HR drops below 40 bpm for more than 10 s, without asys-
tole > 3 s, and BP decreases before HR fall; type IIB: car-
dioinhibition with asystole > 3 s; BP fall coincides with or 
occurs before the HR); and type III, vasodepressor (BP falls 
to a systolic value < 60 mmHg; HR during syncope does not 
fall by more than 10% of its peak value).
HRV analysis
Short-term HRVa was performed, following the ESC guidelines 
[17], at baseline (supine position, 10 min before tilting), at 
the onset of syncope (for HUTT+) or at maximum peak of 
HR after NTG administration, in patients without syncope 
occurrence (HUTT–). 
All parameters were calculated with the Kubios HRV 
software, version 2.1 [18] from 2-min segments in the time-do-
main, frequency-domain (with the fast Fourier transform [FFT], 
and with the autoregressive model [AR]), and with non-linear 
methods (Table 1) [12, 17].
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Statistical analysis
Statistical calculations were performed with SPSS software, 
version 21.0 (SPSS Inc., Chicago, Illinois) [19]. Continuous 
variables are presented as mean ± standard deviation (SD). 
The t-test and the Mann-Whitney-Wilcoxon nonparametric 
test were used to determine differences between groups (or 
subgroups), considering p < 0.05 as statistically significant.
HRV parameters were compared among subgroups of 
patients, clustered on the basis of PsyP and HUTT results. 
Linear discriminant analysis (LDA) [20] was used to 
evaluate which HRV parameters, alone and/or in combina-
tion, could provide a separation among the subgroups. LDA 
searches for linear combinations of the input features that 
can provide an adequate separation between two or more 
classes. The discriminant functions used by LDA are built up 
as a linear combination of the variables that seek to maximise 
the differences between the classes [12, 20]. The classification 
accuracy of the method is defined as the ability to discriminate 
between the investigated groups. 
RESULTS
The majority (76%) of the enrolled patients had experienced 
only one episode of TloC at the time of the study.  
Overall, 24/41 (58.5%) patients had abnormal PsyP 
(PsyP+), while 17/41 patients had normal psychological 
pattern. 
No patient had spontaneous syncope during the first 
20 min of HUTT. 17/41 patients (41.4%) had an NTG-induced 
positive response to HUTT (two cardio-inhibitor type; six 
mixed type; nine vasodepressor type). Out of them, only five 









RR mean ms Mean of RR intervals
SDNN ms Standard deviation of RR intervals
RMSSD ms Square root of the mean squared differences between successive RR intervals
NN50   Number of successive RR interval pairs that differ more than 50 ms
PNN50 % NN50 divided by the total number of RR intervals











LFpowFFT ms2 Absolute power of VLF, LF, and HF bands
HFpowFFT                                                                                             Fast Fourier transform
LF/HF FFT   Ratio between LF and HF band powers
VLFpowAR    
LFpowAR ms2 Absolute power of VLF, LF, and HF bands 
HFpowAR    
VLFpowprAR % Relative power of VLF, LF and HF bands                                Autoregressive model
totpowAR ms2  






SD1/SD2   Ratio between SD1 and SD2
SD1 ms Standard deviation of the Poincarè plot perpendicular to the line of identity
SD2 ms Standard deviation of the Poincarè plot along the line of identity
RPLmean beats Recurrence plot mean line length
RPLmax % Recurrence plot maximum line length
rprec % Recurrence plot recurrence rate
rpadet   Recurrence plot determinism
rpshen   Recurrence plot Shannon entropy
DFA1   Detrended fluctuation short term fluctuation slope
DFA2   Detrended fluctuation long term fluctuation slope
apen   Approximated entropy
sampen   Sample entropy
d2   Correlation dimension
Abbreviations — see text
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(12%) patients with normal PsyP had NTG-induced syncope 
at HUTT. By integrating the results of PsyP and HUTT, four 
subgroups were identified, the HRVa parameters of which are 
summarised in Table 2:
 — group 1A (12 patients) with PsyP+ and HUTT+;
 — group 2A (12 patients) with PsyP+ and HUTT–;
 — group 1B (5 patients) with PsyP– and HUTT+;
 — group 2B (12 patients) with PsyP– and HUTT–.
Based on HRVa, it was found that patients with history of 
TLoC and abnormal PsyP may have different patterns of CANS 
modulation at baseline rest and/or at the peak of NTG-induced 
vasodilatation during HUTT, which correlate with and are pre-
dictive of the induction of syncope at HUTT (Table 3).
In fact, among PsyP+ patients, a significant dominance 
of sympathetic modulation was found in those with HUTT+ 
(group 1A) compared with those with HUTT– (group 2A), 
both at rest (> low frequency [LV] power) and at the peak 
HUTT response (> very low frequency [VLF] power, > LVpow-
er%, > DFA2 and > rprec). In fact, in group 1A, a 60% incre-
ment of LVpower and 530% increment of VLFpower were 
found immediately before syncope. 
Instead, in PsyP– patients (groups 1B and 2B), a preva-
lence of vagal modulation (< SDNN/RMSSD, < LVpower, 
and < LF/HF (1.2–1.4); > high frequency [HF] power, > tot-
power, > SD1/SD2, > sampen) in group 1B, or a physi-
ological sympatho-vagal balance in group 2B were found 
at rest (Table 2). At the LDA, the combination of basal 
SDNN/RMSSD, totpower, SD1/SD2, and sampen in the 
formula: F1 = (0.26 × SDNN/RMSSD) + (0.003 × totpow-
er) + (2.935 × SD1/SD2) + (1.85 × sampen) + (–2.934), 
provided 94% of discriminant accuracy (cross correlated), 
identifying HUTT+ response, if F1 < 0. 
Furthermore, among PsyP– patients, syncope did not 
occur (group 2B) when, besides a balanced sympatho-vagal 
modulation at rest, VLFpower did not increase significantly after 
NTG administration. Instead, four-fold (VLFpower) to ten-fold 
(LFpower) increment of sympathetic activation was associated 
with the occurrence of NTG-induced syncope (in group 1B). 
At peak NTG-induced HR (HUTT–) or syncope (HUTT+), 
VLFpower, LFpower, DFA1 were significantly different.
These findings support the hypothesis that CANS imbal-
ance towards an abnormal sympathetic dominance could be 
one of the mechanism favouring the occurrence of syncope 
in patients with abnormal PsyP.
Interestingly, the behaviour of VLFpower correlates sig-
nificantly with the occurrence of syncope, its increment being 
highly correlated with HUTT+ response, independently of 
PsyP. In fact, as shown in Table 2, among HUTT+ patients 
VLFpower increased from 65.6 ms2 (at rest) to 409.6 ms2 (at 
syncope) in group 1A (+524%), and from 27.4 ms2 (at rest) 
to 636.0 ms2 (at syncope) in group 1B (+2221%). Conversely, 
in HUTT– patients a decrease in VLFpower (if compared to 
rest values) was found at the moment of max NTG-induced 
HR peak in group 2A (PsyP+), whereas average VLFpower 
remained almost unchanged, if compared to baseline values 
in PsyP– patients (group 2B). 
In HUTT + patients, the timing of maximum VLFpeak 
with respect to the onset of syncope was different depend-
ing on the mechanism of syncope (Fig. 1). In fact, maximum 
VLFpeak occurred after the onset of syncope in the cardio-
depressor type (Type 2b), followed the onset of syncope in 
the vasodepressor type (Type 3), while it occurred almost 
simultaneously in the mixed type (Type 1).
No significant differences were observed between pa-
tients with just one and patients with more than one episode 
of TLoC before the study session.
DISCUSSION
Although widely investigated with methods and algorithms 
standardised in international guidelines [3], the pathophysiol-
Table 3. Different patterns of cardiovascular autonomic nervous system modulation among patients group
 HUTT Psychological assessment
Abnormal psychological profile (n = 24) Normal psychological profile (n = 17)
Baseline rest Syncope Peak HR Baseline rest Syncope Peak HR














Group 2A (n = 12) Group 2B (n = 12)













HR — heart rate; HUTT — head-up tilt test; other abbreviations — see text
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ogy of TLoC occurring in the absence of structural cardiovas-
cular and/or neurological disorders is not yet fully elucidated 
and may still represent a diagnostic challenge. In particular, 
the mechanistic role of psychological factors in the genesis 
of TLoC is still undefined, although a higher prevalence of 
anxiety and depression in patients with TLoC compared to 
age-matched normal subjects has been reported [8, 9]. Such 
evidence was confirmed also in the present study.
Considering the possible role of psychological factors in 
the aetiology and in the response to treatment of neurally 
mediated and unexplained syncope [2, 5], we investigated the 
hypothesis that different CANS modulation could be found in 
patients with evidence of abnormal PsyP, at baseline rest and 
during HUTT, which would be useful in the understanding 
of the possible role of anxiety as an individual mechanism 
of TLoC.
Figure 1. Time-varying changes of very low frequency (VLF) 
power during head-up tilt test (HUTT) in three HUTT+ patients 
with different kinds of neurally mediated syncope. The vertical 
arrows indicate the onset of syncope; Type 2b — cardiodepres-
sor; Type 1 —  mixed; Type 3 — vasodepressor; NTG — nitro-
glicerine
By integrating PsyP, HRVa, and pharmacologically poten-
tiated HUTT, we found that: among PsyP+ patients, CANS 
pattern of those developing syncope at HUTT (group 1A) was 
characterised by the prevalence of sympathetic modulation at 
baseline rest, which was enhanced at the onset of syncope, 
with 60% increment of LFpower and 530% increment of 
VLFpower; instead, in those with negative HUTT (group 2A) 
a balanced sympatho-vagal modulation was found at base-
line rest, with lower (if compared to group 1A) increment of 
LFpower and remarkable decrease of VLFpower at the peak 
of NTG-induced HR increment.  
Among PsyP– patients, the CANS pattern of those devel-
oping syncope at HUTT (group 1B), despite parasympathetic 
prevalence at rest, was reverting to marked sympathetic domi-
nance at the onset of syncope; instead, the CANS pattern 
of subjects with negative HUTT response (group 2B) was 
characterised by physiological sympatho-vagal balance both 
at baseline rest and the moment of maximum HR increase, 
after NTG administration, with more stable HRV parameters, 
including non-significant changes of VLFpower (Table 3). 
In patients with HUTT+ response, a considerable in-
crease of VLFpower was found at the onset of syncope as 
compared to rest condition in all of them, independently of 
PsyP. However, the quantitative increment of sympathetic 
activation indices was much higher (i.e. four-fold increment 
of VLFpower and ten-fold increment of LFpower) in group 
1B than in group 1A. Instead, in HUTT– patients, a physi-
ological sympatho-vagal balance or prevalence of vagal 
modulation was found in baseline conditions, with opposite 
changes of LFpower and of VLFpower at the moment of max 
NTG-induced HR. Thus, in this study, VLFpower was a highly 
sensitive parameter to differentiate HUTT+ from HUTT– pa-
tients, also showing clear-cut differences in HUTT+ patients, 
as a function of PsyP.  
The physiological explanation and mechanisms generat-
ing the VLF component of HRV have not been fully elucidated 
yet. However, besides autonomic nervous system activity 
related to thermoregulation, the renin-angiotensin system, and 
other hormonal factors, recent experimental findings suggest 
that the “VLF rhythm” is intrinsically generated by the heart 
itself, and that the modulation and frequency of this rhythm 
occurs through efferent sympathetic activity, increasing before 
waking, with physical activity, stress response, and other fac-
tors that enhance efferent sympathetic activation [21]. A nor-
mal VLFpower is considered and indicator of healthy function, 
and low VLFpower has been associated with post-traumatic 
stress disorders [22]. Interestingly, we found that HUTT+ 
response was associated with significant enhancement of 
VLFpower (much higher in PsyP– patients), occurring with dif-
ferent timing in respect of the onset of syncope depending on 
the kind of neurally mediated mechanism (Fig. 1). Conversely, 
a lack of VLFpower increment during HUTT and after NTG 
correlated with HUTT– response.
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Limitations of the study
One obvious limitation is the relatively low number of patients 
included (especially in group 1B), which was mainly due to the 
retrospective design of the study. In fact, since the administra-
tion of psychological tests had been routinely proposed, on 
a voluntary basis, only to younger patients, and after clear-cut 
exclusion of any possible structural cardiac or neurological 
abnormality, a significant number of available patients with 
HUTT were excluded because of incomplete or missing psy-
chological datasets. A second limitation of this retrospective 
study is the lack of an age-matched control group of healthy 
subjects without history of TLoC, investigated with the same 
psychological and HRVa investigational protocols. Therefore, 
our results must be considered as purely preliminary and as 
a suggestion for more structured prospective studies.
Despite such limitations, it remains true that patients 
with abnormal PsyP have a higher probability of develop-
ing NTG-induced syncope at HUTT if such a psychological 
profile is associated with enhanced sympathetic modulation. 
Conversely, despite signs of anxiety/depression, a physiologi-
cal sympatho-vagal balance is maintained and patients are 
“protected” from NTG-induced syncope at HUTT. In patients 
with a history of TLoC undergoing HUTT, preliminary psycho-
logical profiling and HRVa might improve the understanding 
of individual mechanisms underlying syncope, which would 
be useful to identify people who may need psychological 
support as part of personalised treatment. Nevertheless, 
regarding the HRV analysis, it must be underlined that, 
although widely accepted to estimate the sympatho-vagal 
modulation in psychophysiological research [23], it remains 
only a surrogate for CANS assessment and the results should 
always be interpreted with caution, unless cross-validated 
with simultaneous recording of other independent markers 
of single autonomic components, such as the skin potential 
response, index of sympathetic activity [24].
CONCLUSIONS
In summary, our results show that, in patients with abnormal 
PsyP, baseline prevalence of sympathetic dominance in rest 
condition is predictive of a HUTT+ response. Conversely, 
despite an abnormal PsyP pattern, if baseline CANS shows 
physiological sympatho-vagal balance or prevalent parasympa-
thetic modulation at rest, the probability of syncope at HUTT 
is lower, unless the amount of sympathetic activation induced 
by HUTT potentiated with NTG, is very high, as observed in 
the few HUTT+ cases with normal PsyP (group 1B).
It seems therefore that syncope occurrence is favoured 
when sympathetic dominance is prevalent or less compen-
sated by parasympathetic modulation at rest, or when there 
is a fast and sudden change from vagal modulation (at rest) to 
sympathetic dominance after NTG. This may suggest any ac-
tive intervention addressed to rebalance psychophysiological 
control mechanisms of BP and HR, through moderate physical 
activity and paced respiration, might be useful to reduce anxi-
ety and to improve quality of life of patients with TLoC in the 
absence of structural cardiac or neurological abnormalities. 
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